Horizon Therapeutics says Amgen deal could close earlier than planned if FTC fails to block it
Robert Galbraith | ReutersHorizon Therapeutics expects its $27.8 billion sale to Amgen to close as early as the end of the third quarter, earlier than previously planned — if the Federal Trade Commission's attempt to block the deal fails —…